Status:
COMPLETED
Real Life Dosing of Remicade for Rheumatoid Arthritis in Austria Monitored Over 9 Infusions (Study P03756)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Collaborating Sponsors:
Centocor, Inc.
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
Brief Summary
This is a prospective, open-label, 1-arm, multicenter observational study to determine the average Remicade dosage and time span between 9 infusions in subjects with rheumatoid arthritis (RA)
Detailed Description
This study population was chosen from a non-probability sample.
Eligibility Criteria
Inclusion
- Severe RA (indication according to Austrian labeling).
Exclusion
- According to Summary of Product Characteristics (SPC).
Key Trial Info
Start Date :
March 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
516 Patients enrolled
Trial Details
Trial ID
NCT00725621
Start Date
March 1 2004
End Date
July 1 2010
Last Update
September 3 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.